Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine

Cancer Letters

Volumn 103, Issue 1, 1996, Pages 85-90

  Jeitner, Thomas M ^a,b   Renton, Fiona J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cysteamine; Neoplasia; Neural

Indexed keywords

MERCAPTAMINE; PENICILLAMINE DERIVATIVE; THIOL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

EID: 0030007896     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04200-0     Document Type: Article

References (28)

1. Packer, R.J. (1995) Brain tumors in children. Curr. Opin. Pediatr., 7, 64-72.
2. Alexander, V. (1991) Brain tumor risk among United States nuclear workers. Occup. Med., 6, 695-714.
3. Schwartz, R.B. and Mantello, M.T. (1992) Primary brain tumors in adults. Semin. Ultrasound, CT, MR, 13, 449-472.
4. Donelli, M.G., Zucchetti, M. and D'Incalci, M. (1992) Do anticancer agents reach the tumor target in the human brain. Cancer Chemother. Pharmacol., 30, 251-260.
5. Vecsei, L. and Widerlov, E. (1990) Preclinical and clinical studies with cysteamine and pantethine related to the central nervous system. Prog. Neuropsychopharmacol. Biol. Psychiatry, 14, 835-862.
6. Goutier, R. (1975) Effects on cell growth processes (mitosis, synthesis of nucleic acids and of proteins). In: Sulfur-Containing Radioprotective Agents. Editor: Z.M. Bacq. Pergammon Press, Oxford, pp. 283-301.
7. Bryant, H.U., Holaday, J.W. and Bernton, E.W. (1989) Cysteamine produces dose-related bidirectional immunomodulatory effects in mice. J. Pharmacol. Exp. Ther., 249, 424-429.
8. Benke, P.J., Levcovitz, H., Paupe, J. and Tozman, E. (1990) Scavengers of free radical oxygen affect the generation of low molecular weight DNA in stimulated lymphocytes from patients with systemic lupus erythematosus. Metabolism, 39, 1278-1284.
9. Zerek-Melen, G., Sewerynek, E., Szkudlinski, M., Lewinski, A., Krotewicz, M., Fryczak, J. and Pawlikowski, M. (1989) Suppressing effect of cysteamine on the TSH-stimulated mitotic activity of the rat thyroid follicular cells in vivo. Neuropeptides, 13, 171-174.
10. Jeitner, T.M., Kneale, C.L., Christopherson, R.I. and Hunt, N.H. (1994) Thiol-mediated inhibition of protein kinase C-dependent oxidative events in T cell proliferation. Biochim. Biophys. Acta, 1223, 15-22.
11. Apffel, C.A., Walker, J.E. and Issarescu, S. (1975) Tumor rejection in experimental animals treated with radioprotective thiols. Cancer Res., 35, 429-437.
12. Laske, R., Schaenenberger, H. and Holler, E. (1989) Investigation on the antiproliferative effects of amino acid antagonists targeting for aminoacyl t-RNA syntheses Part II. The antileukaemic effect. Arch. Pharmacol., 322, 847.
13. Watanabe, H., Kamikawa, H., Namikawa, Y., Takashi, T. and Ito, A. (1988) The effects of ranitidine and cysteamine on intestinal neoplasia induced X-irradiation in rats. Acta Pathol. Jpn., 38, 1285-1296.
14. Jeitner, T.M. and Oliver, J.R. (1990) Possible oncostatic action of cysteamine on the pituitary glands of oestrogen-primed hyperprolactinaemic rats. J. Endocrinol., 127, 119-127.
15. Tatsuta, M., Iishi, H., Baba, M., Nakaizumi, A., Uehara, H. and Taniguchi, H. (1991) Enhancement by sulpiride of the inhibitory effects of cysteamine on gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int. J. Cancer, 47, 54-59.
16. Jonas, A.J. and Schneider, J.A. (1982) Plasma cysteamine concentrations in children treated for cystinosis. J. Pediatr., 100, 321-323.
17. Smolin, L.A., Clark, K.F., Thoene, J.G., Gahl, W.A. and Schneider, J.A. (1988) A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr. Res., 23, 616-620.
18. van't Hoff, W.G., Baker, T., Dalton, R.N., Duke, L.C., Smith, S.P., Chantler, C. and Haycock, G.B. (1991) Effects of oral phosphocysteamine and rectal cysteamine in cystinosis. Arch. Dis. Child., 66, 1434-1437.
19. Prescott, L.F., Newton, R.W., Swainson, C.P., Wright, N., Forrest, A.R.W. and Mathews, H. (1974) Successful treatment of severe paracetamol overdose with cysteamine. Lancet, 1, 588-592.
20. Jeitner, T.M. (1994) Cell cycle-dependent inhibition of normal and neoplastic human T cell proliferation by thiol compounds and desferrioxamine. Ph.D. Thesis. University of Sydney.
21. Grdina, D.J. and Nagy, B. (1986) The effect of 2-[(aminopropyl)amino] ethanethiol (WR1065) on radiation-induced DNA damage and repair and cell progression in V79 cells. Br. J. Cancer, 54, 933-941.
22. Jacobsen, F.F., Jenkyn, D.J. and Papadimitriou, J.M. (1987) Four permanent cell lines established from human malignant gliomas: three exhibiting striated muscle differentiation. J. Neuropathol. Exp. Neurol., 46, 431-450.
23. Renton, F.J. and Jeitner, T.M. (1996) Cell cycle-dependent inhibition of human brain tumor cell lines by iron chelators. Biochem. Pharmacol., in press.
24. Takagi, Y., Shikitat, T., Terasima, T. and Akaboshi, S. (1974) Specificity of radioprotective and cytotoxic effects of cysteamine in HeLa S3 cells: generation of hydrogen peroxide. Radiat. Res., 60, 292-301.
25. Biaglow, J.E., Issels, R.W., Gerweck, L.E., Varnes, M.E., Jacobson, J.B., Mitchell, J. and Russo, A. (1984) Factors influencing the oxidation of cysteamine and other thiols: implication for hyperthermic sensitization and radiation protection. Radiat. Res., 100, 298-301.
26. Jeitner, T.M. and Oliver, J.R. (1990) The depletion of plasma prolactin by pantethine in oestrogen-primed hyperprolactinaemic rats. J. Endocrinol., 124, 397-402.
27. Meier, T. and Issels, R.D. (1995) Degradation of 2-(3-aminopropylamino)-ethanethiol (WR 1065) by Cu-dependent amine oxidases and influence of glutathione status of Chinese hamster ovary cells. Biochem. Pharmacol., 50, 489-496.
28. Goldstone, S.D., Fragonas, J.C., Jeitner, T.M. and Hunt, N.H. (1995) Transcription factors as targets for oxidative signalling during lymphocyte activation. Biochim. Biophys. Acta, 1263, 114-122.